SEC Form 4 · accession 0001140361-15-019330
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Hurwitz
Director
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 1:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2015 | J | 18,074 | $0.00 | A | 18,074 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution from Alta BioPharma Management III, LLC., of which the reporting person is a non-managing director.